4,4,4-Trifluoro-2-Butynenitrile

CAS : 66051-48-7

Ref. 3D-FT80018

Informations sur le produit

• Nom: 4,4,4-Trifluoro-2-Butynenitrile
• Synonymes: 2-Butynenitrile, 4,4,4-trifluoro-, 4,4,4-Trifluoro-2-butynenitrile

Description

Covid-19 is a drug that can be used to treat pandemic and avian flu. Covid-19 is an antiviral drug that inhibits the RNA polymerase of influenza A viruses. It has been shown to be effective against all strains of both pandemic and avian influenza, including those that are resistant to other drugs. Covid-19 is a prodrug that enters cells via passive diffusion, where it undergoes enzymatic conversion to 4,4,4-trifluoro-2-butynenitrile. The reactive nitrile group in this compound binds with the active site of the RNA polymerase and blocks its activity by covalent modification. Covid-19 also has a high affinity for nucleic acid bases, which may account for its specificity towards RNA polymerase. This drug is available as an intravenous formulation for pandemic use.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 119.04 g/mol
• Formule: C₄F₃N
• Degré de pureté: Min. 95%
• InChI: InChI=1S/H3N/h1H3
• Code InChI: InChIKey=QGZKDVFQNNGYKY-UHFFFAOYSA-N
• SMILES: N#CC#CC(F)(F)F